Back to search results

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

Abroad (travel likely)RecruitingPHASE4

Conditions

Myocarditis · Heart Failure · Endomyocardial Biopsy · Cardiomyopathies, Secondary · Immunosuppression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland

    Contact: Study coordinator (Krzysztof Ozierański, MD) · krzysztof.ozieranski@wum.edu.pl
    Contact: Principal Investigator (Agata Tymińska, MD, PhD)
    Łukasz Januszkiewicz, MD, PhD (Sub-investigator)
    Cezary Maciejewski, MD (Sub-investigator)
    Contact: Principal Investigator (Krzysztof Ozierański, MD, PhD)
    Maria Boszko, MD (Sub-investigator)
    Aneta Wincewicz, MD (Sub-investigator)
    Emil Brociek (Sub-investigator)
Study leads

  • Marcin Grabowski, Professor

    Study Chair

    Medical University of Warsaw

  • Krzysztof Ozierański, MD, PhD

    Principal Investigator

    Medical University of Warsaw

  • Agata Tymińska, MD, PhD

    Principal Investigator

    Medical University of Warsaw

View source on ClinicalTrials.gov(opens in a new tab)